
Recently, Mr. Joe Huntsman, the new CEO and owner of the Roanoke Area MS Center and Blue Ridge Neurology in Christiansburg was kind enough to answer some of the more common questions we have been hearing at the MS Alliance of Virginia regarding Dr. Jill Cramer’s retirement and subsequent purchase of her practice by BrookWell Infusion. Read below to hear what he has to say…
MSAV – When will the new neurologists and other providers be available to see patients, and how can appointments be scheduled?
Mr. Huntsman – The new neurology full team will begin to see patients in September and appointments are already being scheduled. However, we are providing infusions for several insurance plans this summer (already).
MSAV – What is the procedure for patients with existing referrals or those who have previously received care at the MS Center to return for appointments?
Mr. Huntsman – If a patient has received care at the Roanoke MS Center in Salem or Blue Ridge Associates in Neurology in Christiansburg in the past, we do not need a new referral unless insurance requires it. Simply a call to schedule an appointment is all that is needed. We truly hope that all patients return, and it would be an honor to serve each of them…….. Read more by clicking HERE!


NORML Op-Ed: Marijuana Prohibition Has Been a Fraud From the Get-Go
Since its inception, efforts to criminalize marijuana and to stigmatize those who consume it have been based upon hyperbole, stereotypes and outright lies. The initial push for cannabis criminalization, which began in earnest more than a century ago, had little to do...
Survey: Adults Seeking Marijuana-Related Advice Seldom Refer to Healthcare Providers or Government Agencies
Few adults turn to either healthcare providers or government agencies when seeking information about cannabis, according to nationwide survey data published in the Journal of Cannabis Research. Researchers with the University of Michigan at Ann Arbor surveyed over...
Nerve Stimulator For Myelin Repair to Enter RRMS Clinical Trial
SetPoint Medical is planning to launch a clinical trial next year to investigate its nerve stimulator device, intending to support myelin repair, in people with relapsing-remitting multiple sclerosis (RRMS). The announcement comes after U.S. Food and Drug...
FDA Approves Ocrevus Zunovo™ as the First and Only Twice-A-Year 10-Minute Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis
South San Francisco, CA -- September 13, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the United States Food and Drug Administration (U.S. FDA) has approved Ocrevus Zunovo™ (ocrelizumab & hyaluronidase-ocsq) for...
Human Toxicity From COVID-19 Rapid Home Test Kits
The persistence of the COVID-19 pandemic has necessitated the development and widespread availability of methods to detect the COVID-19 virus in humans. COVID-19 tests, which were initially only available in healthcare facility settings, are now manufactured for home...